J. Dunst et al., Bladder preservation in muscle-invasive bladder cancer by conservative surgery and radiochemotherapy, SEM SURG ON, 20(1), 2001, pp. 24-32
Organ preservation has been investigated in muscle-invasive bladder cancer
over the past decades as an alternative to standard radical cystectomy. The
results of large prospective protocols and population-based studies sugges
t that an organ-preserving approach is possible without deferring the survi
val probability. Organ preservation requires a trimodal schedule, including
transurethral surgery (transurethral resection of bladder tumor (TURBT)),
radiation, and chemotherapy. A complete TURBT is the most important single
prognostic factor, and should be attempted. Radiotherapy, in conjunction wi
th concurrent platinum-based chemotherapy, can control the vast majority of
urothelial bladder tumors. The histologically-proven complete remission ra
tes of macroscopic tumors (unresectable by TURBT) lie in the range of about
70%. After radiochemotherapy, a histological response evaluation with repe
ated TURBT is recommended. Patients with residual tumor require salvage cys
tectomy. In cases of complete remission, patients can maintain their bladde
rs but they should be closely followed over years. The risk of severe late-
radiation sequelae is low, in the range of less than 5%. About 75% of long-
term survivors maintain a normally functioning bladder. (C) 2001 Wiley-Liss
, Inc.